Concepedia

Robert Halford

RH

Statistics

Publications

3

Citations

64

H-Index

3

Active since

2013

Affiliations

Princess Margaret Cancer Centre(Current)

National Cancer Institute

Robert Halford is an author at Princess Margaret Cancer Centre specializing in medicine, oncology, and malignant neoplasms.

Publications per year

2013–2016

3

Publications

3

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium

Srikala S. Sridhar, Mary J. MacKenzie, Sebastién J. Hotte et al. · Investigational New Drugs · 2013 · 28 citations

, , +14

Modeling the Agility MLC in the Monaco treatment planning system

M Snyder, Robert Halford, Cory Knill et al. · Journal of Applied Clinical Medical Physics · 2016 · 21 citations · Full text

, , +16

A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium

Stéphanie Lheureux, Amit M. Oza, Scott A. Laurie et al. · British Journal of Cancer · 2015 · 15 citations · Full text

, , +16

1–3 of 3